Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

424 Tumour-homing T cells in the blood predict the efficacy of anti-PD-1 immunotherapy in melanoma patients

  • Shahneen Sandhu1
  • Anupama Pasam2
  • Andreas Behren3
  • Jessica da Gama Duarte4
  • Tessa Gargett5
  • Rebecca Ormsby6
  • Gonzalo Tapia-Rico7
  • Nga TH Truong8
  • Nicholas I Warnock8
  • Luke T Quigley4
  • Vanessa Vaz8
  • Erica CF Yeo8
4 more authors
  • Bree Hodgson9
  • Santosh I Poonnoose10
  • Michael P Brown11
  • Lisa M Ebert8
11 affiliations
  1. 17 Sir Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  2. 2Aff1 grid.414094.c0000000101627225The Ludwig Institute for Cancer Research Melbourne VIC Australia
  3. 31Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia
  4. 4Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia
  5. 51Centre for Cancer Biology, Adelaide, SA, Australia
  6. 6Flinders Health and Medical Research Institute, Flinders University, Adelaide, South Australia, Australia
  7. 74Icon Cancer Centre, Adelaide, SA, Australia
  8. 8Adelaide University, Adelaide, SA, Australia
  9. 9Flinders University, Adelaide, SA, Australia
  10. 10Flinders Medical Centre, Adelaide, SA, Australia
  11. 11Royal Adelaide Hospital, Adelaide, SA, Australia
Open at sourcePDFDOICite

Related

  1. Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study
    Zirui Xue, Dan Liu, Zhaodong Sun +6
    Cancer reports (Hoboken, N.J.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. A first-in-human, phase I/IIa trial of the T cell immunotherapy personalised tumour trained lymphocytes in patients with advanced colorectal cancer: Study protocol
    Ahmed Tarfy, Andrea Salmén, Guro Gafvelin +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  3. Efficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial protocol
    Jin Li, Nianlan Zhou, Saiquan Lu +4
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossref
  4. Tumour-absorbed dose and efficacy of peptide receptor radionuclide therapy with [90Y]Y-DOTATOC in patients with refractory meningioma: a single-centre experience
    Lilit Schweiger, Giulia Santo, Ariane Kronthaler +6
    European Journal of Nuclear Medicine and Molecular ImagingPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  5. Population PK/PD Modeling and Simulation to Predict the Comparative Long-Term Efficacy of Olokizumab in Rheumatoid Arthritis Patients.
    Yuri Kosinsky, Ivan Azarov, Kirill Zhudenkov +7
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{sandhu2026tumourhoming,
  title = {{424 Tumour-homing T cells in the blood predict the efficacy of anti-PD-1 immunotherapy in melanoma patients}},
  author = {Shahneen Sandhu and Anupama Pasam and Andreas Behren and Jessica da Gama Duarte and Tessa Gargett and Rebecca Ormsby and Gonzalo Tapia-Rico and Nga TH Truong and Nicholas I Warnock and Luke T Quigley and Vanessa Vaz and Erica CF Yeo and Bree Hodgson and Santosh I Poonnoose and Michael P Brown and Lisa M Ebert},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0424},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0424},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 424 Tumour-homing T cells in the blood predict the efficacy of anti-PD-1 immunotherapy in melanoma patients
AU  - Shahneen Sandhu
AU  - Anupama Pasam
AU  - Andreas Behren
AU  - Jessica da Gama Duarte
AU  - Tessa Gargett
AU  - Rebecca Ormsby
AU  - Gonzalo Tapia-Rico
AU  - Nga TH Truong
AU  - Nicholas I Warnock
AU  - Luke T Quigley
AU  - Vanessa Vaz
AU  - Erica CF Yeo
AU  - Bree Hodgson
AU  - Santosh I Poonnoose
AU  - Michael P Brown
AU  - Lisa M Ebert
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0424
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0424
SN  - 2051-1426
ER  -